Erythrocytosis, familial, 4

MONDO:0012729

Any familial polycythemia in which the cause of the disease is a mutation in the EPAS1 gene.

Also known as: EPAS1 familial polycythemia, erythrocytosis, familial, 4, erythrocytosis, familial, type 4, familial polycythemia caused by mutation in EPAS1, ECYT4

3 clinical trials for this condition and its sub-types, 2 tagged with Erythrocytosis, familial, 4 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Familial polycythemia (92)

Including sub-types (3) Tagged with Erythrocytosis, familial, 4 (2)

Trials to join now! 1 Completed 2

New drug combo targets Hard-to-Treat kidney cancer

Disease control Recruiting now

This early-stage study tests a new drug called casdatifan (AB521) alone or combined with other cancer drugs in people with advanced clear cell kidney cancer or other solid tumors. The main goals are to check safety and find the right dose. About 362 participants will take part.

Phase 1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control

Last updated Sep 02, 2026 00:00 UTC

Erythrocytosis, familial, 4

Where it sits in the disease tree

New drug combo targets Hard-to-Treat kidney cancer